A medication management device developed by Israeli firm Vaica Medical improved anti-rejection medication adherence in teen and young adult kidney transplant recipients in the TAKE IT trial. Results of the randomized trial, led by Bethany Foster of McGill University in Montreal, are now published online by the American Journal of Kidney Disease.
TAKE IT is designed to assess if a regular program of coaching, electronically-monitored adherence, and Vaica’s SimpleMed electronic pillbox could...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?